Eton Pharmaceuticals Inc (NASDAQ: ETON) shares dropped 17.89%, or $1.05 per share, to close Monday at $4.82. After opening the day at $5.26, shares of Eton fluctuated between $5.26 and $4.78. 2,987,689 shares traded hands an increase from their 30 day average of 465,341. Monday’s activity brought Eton’s market cap to $118,126,709.
About Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKINDI® SPRINKLE, Biorphen®, and Alaway® Preservative Free, and has six additional products that have been submitted to the FDA.